Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching
Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Eteläuomen Läi United States Fernando Carlos Proen Luizo Assagra Fernando Baldi Juanj Chamie Quintero
Source: floppingaces.net